Safety of exenatide once weekly for 52 weeks in Japanese patients with type 2 diabetes mellitus

AIMS/INTRODUCTION: An initial 26‐week, randomized, open‐label study compared the efficacy and safety of exenatide 10 mcg twice daily with exenatide 2 mg once weekly in Asian patients with type 2 diabetes who experienced inadequate glycemic control with oral antidiabetes medications. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Onishi, Yukiko, Koshiyama, Hiroyuki, Imaoka, Takeshi, Haber, Harry, Scism‐Bacon, Jamie, Boardman, Marilyn K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley-Blackwell 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019273/
https://www.ncbi.nlm.nih.gov/pubmed/24843650
http://dx.doi.org/10.1111/jdi.12000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019273/
https://www.ncbi.nlm.nih.gov/pubmed/24843650
http://dx.doi.org/10.1111/jdi.12000

Ejemplares similares